今海国际(02225)：刘镭获委任为首席科学官
今海国际(02225)发布公告，刘镭(为公司间接全资附属公司上海今海医疗科技有限公司(今海医疗)董事及总经理)获委任为集团首席科学官，由2023年12月1日起生效，初步任期为3年，主要负责为今海医疗的产品取得证书并进行研发，监督其他新产品及新技术的实施，以确保彼等将符合集团的长期发展战略。
Reprinted from 引领外汇网，the copyright all reserved by the original author.
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
If you like, reward to support.
Hot
No comment on record. Start new comment.